TY - JOUR
AU - J. R. Covvey
AU - M. L. Blakely
AU - R. Singh
AU - A. M. Peckham
AU - K. E. Evoy
A1 - 
AD - Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA. Electronic address: covveyj@duq.edu.; University of Wyoming School of Pharmacy, 1000 E University Ave, Laramie, WY, 82071, USA. Electronic address: Michelle.Blakely@uwyo.edu.; University of Wyoming School of Pharmacy, 1000 E University Ave, Laramie, WY, 82071, USA. Electronic address: rsingh5@uwyo.edu.; Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02115, USA. Electronic address: alyssampeckham@gmail.com.; The University of Texas at Austin College of Pharmacy, USA; UT Health San Antonio School of Medicine, 7703 Floyd Curl Drive - MC 6220; San Antonio, TX, 78229, USA. Electronic address: evoy@uthscsa.edu.
AN - 36503683
BT - Res Social Adm Pharm
C5 - Opioids & Substance Use; Education & Workforce
CP - 4
DA - Apr
DO - 10.1016/j.sapharm.2022.12.001
DP - NLM
ET - 20221205
IS - 4
JF - Res Social Adm Pharm
LA - eng
PY - 2023
SN - 1551-7411
SP - 599
EP - 609+
ST - Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse
T1 - Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse
T2 - Res Social Adm Pharm
TI - Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse
U1 - Opioids & Substance Use; Education & Workforce
U3 - 10.1016/j.sapharm.2022.12.001
VL - 19
VO - 1551-7411
Y1 - 2023
ER -